{"id":"https://openalex.org/W4416635953","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4574","title":"The number needed to treat with dupilumab to prevent moderate or severe chronic obstructive pulmonary disease exacerbations: BOREAS and NOTUS","display_name":"The number needed to treat with dupilumab to prevent moderate or severe chronic obstructive pulmonary disease exacerbations: BOREAS and NOTUS","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416635953","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4574"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa4574","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4574","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4574","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046399622","display_name":"Surya Prakash Bhatt","orcid":"https://orcid.org/0000-0002-8418-4497","observed_orcids":["https://orcid.org/0000-0002-8418-4497"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surya P. Bhatt","raw_affiliation_strings":["1University of Alabama at Birmingham, Birmingham, AL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Alabama at Birmingham, Birmingham, AL, United States","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100767595","display_name":"Fernando J. Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2412-3182","observed_orcids":["https://orcid.org/0000-0002-2412-3182"]},"institutions":[{"id":"https://openalex.org/I4405272987","display_name":"Weill Cornell Medical Center","ror":"https://ror.org/052v90092","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466","https://openalex.org/I4405272987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando J. Martinez","raw_affiliation_strings":["2New York-Presbyterian/Weill Cornell Medical Center, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2New York-Presbyterian/Weill Cornell Medical Center, New York, NY, United States","institution_ids":["https://openalex.org/I4405272987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021493691","display_name":"Nicola Alexander Hanania","orcid":"https://orcid.org/0000-0003-3087-9530","observed_orcids":["https://orcid.org/0000-0003-3087-9530"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicola Hanania","raw_affiliation_strings":["3Baylor College of Medicine, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Baylor College of Medicine, Houston, TX, United States","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028265360","display_name":"Klaus Friedrich Rabe","orcid":"https://orcid.org/0000-0002-7020-1401","observed_orcids":["https://orcid.org/0000-0002-7020-1401"]},"institutions":[{"id":"https://openalex.org/I4210129183","display_name":"German Center for Lung Research","ror":"https://ror.org/03dx11k66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210129183","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus F. Rabe","raw_affiliation_strings":["4LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany","institution_ids":["https://openalex.org/I4210129183","https://openalex.org/I4210140903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100402981","display_name":"Min Zhang","orcid":"https://orcid.org/0000-0003-1657-1337","observed_orcids":["https://orcid.org/0000-0003-1657-1337"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Zhang","raw_affiliation_strings":["5Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I183067930"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Changming Xia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changming Xia","raw_affiliation_strings":["6Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108694569","display_name":"Ernesto Mayen Herrera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernesto Mayen Herrera","raw_affiliation_strings":["7Sanofi, Bridgewater, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Sanofi, Bridgewater, NJ, United States","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002211601","display_name":"Vijay K. T. Alagappan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vijay Alagappan","raw_affiliation_strings":["6Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States","institution_ids":["https://openalex.org/I186523950"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4574","last_page":"PA4574"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9670000076293945},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.9940000176429749},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.9539999961853027},{"id":"https://openalex.org/keywords/type-2-inflammation","display_name":"type 2 inflammation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/blood-eosinophils","display_name":"blood eosinophils","score":0.8270000219345093},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.5989999771118164},{"id":"https://openalex.org/keywords/risk-difference","display_name":"risk difference","score":0.6050000190734863},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.9488000273704529},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8503000140190125},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.8029999732971191},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7545999884605408},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.7408999800682068},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5662999749183655},{"id":"https://openalex.org/C67774102","wikidata":"https://www.wikidata.org/wiki/Q614132","display_name":"Number needed to treat","level":4,"score":0.5641000270843506},{"id":"https://openalex.org/C111278954","wikidata":"https://www.wikidata.org/wiki/Q17069312","display_name":"Minimal clinically important difference","level":3,"score":0.4553000032901764},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3783999979496002},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.3425999879837036},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.33500000834465027},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3255000114440918},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.30649998784065247},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.29789999127388},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.2971000075340271},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2842999994754791},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.2799000144004822},{"id":"https://openalex.org/C2910217193","wikidata":"https://www.wikidata.org/wiki/Q4677923","display_name":"Copd exacerbation","level":4,"score":0.2709999978542328},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.26489999890327454},{"id":"https://openalex.org/C2776485726","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Rescue therapy","level":2,"score":0.25450000166893005},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa4574","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4574","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4574","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7166158222","https://openalex.org/W7167456425","https://openalex.org/W4404096813","https://openalex.org/W4408555488","https://openalex.org/W4408555365","https://openalex.org/W4416638880","https://openalex.org/W4410268280","https://openalex.org/W4407340280","https://openalex.org/W4404046556","https://openalex.org/W4416102523"],"abstract_inverted_index":{"Background:":[0],"The":[1],"number":[2],"needed":[3],"to":[4,65,216],"treat":[5],"(NNT)":[6],"is":[7],"a":[8,22],"simple":[9],"and":[10,31,40,45,53,77,84,101,149,151,165,174,203,234],"intuitive":[11],"statistical":[12],"measure":[13],"that":[14,96],"quantifies":[15],"treatment":[16],"benefits":[17],"for":[18,122,225,239],"individual":[19],"patients.":[20],"Dupilumab,":[21,212],"human":[23],"monoclonal":[24],"antibody,":[25],"blocks":[26],"signaling":[27],"of":[28,34,128,143],"interleukin-4/13,":[29],"key":[30],"central":[32],"drivers":[33],"type":[35,54,102,235],"2":[36,55,103,236],"inflammation.":[37,56],"In":[38,160],"BOREAS":[39,76,80],"NOTUS,":[41],"dupilumab":[42,63,116,148,175],"reduced":[43,180],"exacerbations":[44,71,132],"improved":[46],"lung":[47],"function":[48],"in":[49],"patients":[50,98,228],"with":[51,99,229],"COPD":[52,70,100],"Aims":[57],"&":[58],"objectives:":[59],"To":[60],"determine":[61],"the":[62,141],"NNT":[64,152,204],"prevent":[66],"moderate":[67,129,182,221],"or":[68,120,130,183,222],"severe":[69,131,184,223],"using":[72],"pooled":[73,161],"data":[74],"from":[75],"NOTUS.":[78],"Methods:":[79],"(":[81,86],"NCT03930732":[82],")":[83,88],"NOTUS":[85],"NCT04456673":[87],"were":[89,133,168],"phase":[90],"3,":[91],"randomized,":[92],"double-blind,":[93],"placebo-controlled":[94],"trials":[95],"enrolled":[97],"inflammation":[104],"(screening":[105],"blood":[106],"eosinophils":[107],"\u2265300":[108],"cells/\u00b5L)":[109],"on":[110],"triple":[111,217],"therapy.":[112],"Patients":[113],"received":[114],"add-on":[115,215],"300":[117],"mg":[118],"q2w":[119],"placebo":[121,173,179],"52":[123,240],"weeks.":[124,241],"Adjusted":[125],"annualized":[126,145,181],"rates":[127,146],"assessed,":[134],"absolute":[135],"risk":[136,157,188,195],"difference":[137,142,196],"was":[138,153,199,207],"derived":[139],"as":[140,213],"adjusted":[144],"between":[147],"placebo,":[150],"calculated":[154],"by":[155],"1/absolute":[156],"difference.":[158],"Results:":[159],"analysis,":[162],"baseline":[163],"demographic":[164],"disease":[166],"characteristics":[167],"broadly":[169],"similar":[170],"across":[171],"both":[172],"groups.":[176],"Dupilumab":[177],"vs":[178],"exacerbation":[185,224,232],"rate":[186],"(relative":[187],"[95%":[189],"CI]:":[190],"0.69":[191],"[0.59,":[192],"0.79];":[193],"P<0.001);":[194],"(95%":[197,205],"CI)":[198,206],"\u20130.36":[200],"(\u20130.51,":[201],"\u20130.22)":[202],"2.74":[208],"(1.96,":[209],"4.58).":[210],"Conclusions:":[211],"an":[214],"therapy,":[218],"prevented":[219],"1":[220],"every":[226],"3":[227],"COPD,":[230],"high":[231],"risk,":[233],"inflammation,":[237],"treated":[238]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}